ACE2 and metabolic syndrome: With regard to MR association studies that assessed inflammation markers and COVID-19 outcomes, of the 12 identified studies, there were studies examining either protein-related inflammatory markers, ACE2 expression, or other markers related to inflammation and metabolic syndrome/cardiovascular disease risk factors.